Diuretic use during kidney transplant to help the new kidney work faster
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether giving a diuretic (a medication that helps flush fluids) during kidney transplant surgery helps a deceased-donor kidney start working sooner after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must be scheduled to receive a kidney from a deceased donor
- You cannot be allergic to mannitol or furosemide (the diuretics used in the trial)
- You must not be receiving another organ, like a pancreas or liver, at the same time as the kidney
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called vonoprazan fumarate can help prevent delayed kidney function after a first kidney transplant from a deceased donor. It is for people who are ready to follow standard post-transplant care.
This study looks at a new way to monitor your kidney health and improve care after a deceased donor transplant where your kidney was slow to start working. It uses a simple blood test to check how your new kidney is doing and helps your care team coordinate better.
This study looks at ways to prevent delayed graft function — when a new kidney is slow to start working after transplant. It is open to adults receiving a kidney from a living or deceased donor, and it may help your new kidney work better sooner.
This study tests a special solution given to the donor kidney during storage and transport, which may help protect the kidney before transplant. It is for adults with kidney failure receiving a deceased donor kidney.
This study looks at ways to help a donated kidney work better after transplant. It is intended for people who are receiving a living-donor kidney transplant due to kidney failure.
This trial studies a sedative drug called dexmedetomidine given during kidney transplant surgery to see if it helps protect the new kidney. It might help the kidney work better after the operation.
Hear when a new Delayed Graft Function trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.